Search results
Results from the WOW.Com Content Network
The term natural health product (NHP) is used in Canada to describe substances such as vitamins and minerals, herbal medicines, homeopathic preparations, energy drinks, probiotics, and many alternative and traditional medicines. [1] A 2010 survey showed that 73% of Canadians consume NHP on a regular basis.
The issuance of Natural Health Product Numbers (NPNs), required for each nutritional marketed in Canada. Each product is evaluated for formulation, dosage requirements, label claims, safety, and proof of efficacy prior to granting an NPN.
National Health Service: NICE: National Institute for Health and Clinical Excellence: NKC: Northwest Kidney Centers: NKF: National Kidney Foundation: NYHA: New York Heart Association: NPS: National Prescribing Service (Australia) NPSA: National Pharmaceutical Services Association: NREMT: National Registry of Emergency Medical Technicians(ORG) NREMR
by health care providers on prescriptions (however, the NPI will not replace requirements for the DEA number or state license number); by health plans in their internal provider files to process transactions and communicate with health care providers; by health plans to coordinate benefits with other health plans;
NPN may refer to: Science and technology. Next Protocol Negotiation, ... Natural Health Product Number, required by the Canadian Natural Health Products Directorate
The federal Hazardous Products Act and associated Controlled Products Regulations, administered by the Workplace Hazardous Materials Bureau residing in the federal Department of Health Canada, [citation needed] established the national standard for chemical classification and hazard communication in Canada and is the foundation for the workers' "right-to-know" legislation enacted in each of ...
Health Canada (HC; French: Santé Canada, SC) [NB 1] is the department of the Government of Canada responsible for national health policy. The department itself is also responsible for numerous federal health-related agencies, including the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC), among others.
Once a drug has been approved, the Therapeutic Products Directorate issues a DIN, which permits the manufacturer to market the drug in Canada. For drugs, where there is minimal market history in Canada, there is a more stringent review and the drug is required to have a Notice of Compliance and a DIN in order to be marketed in Canada.